NRG Oncology/NSABP B-31: Stromal tumor infiltrating lymphocytes (sTILs) and outcomes in early-stage HER2-positive breast cancer (BC).

Rim S. Kim,Nan Song,Patrick G. Gavin,Roberto Salgado,Hanna Bandos,Zuzana Kos,Giuseppe Floris,Gert Van den Eynden,Sunil Badve,Priya Rastogi,Louis Fehrenbacher,Eleftherios P. Mamounas,Sandra M. Swain,D L Wickerham,Peter C. Lucas,Joseph P. Costantino,Charles E. Geyer,Norman Wolmark,Soonmyung Paik,Katherine L. Pogue-Geile

NRG Oncology/NSABP B-31: Stromal tumor infiltrating lymphocytes (sTILs) and outcomes in early-stage HER2-positive breast cancer (BC).

2018

12010Background: Stromal tumor infiltrating lymphocytes (sTILs) in HER2-positive and triple-negative breast cancer (BC) are associated with prognosis and treatment response. NSABP B-31 evaluated ch...

Keywords:

HER2 Positive Breast Cancer
Stromal tumor
Internal medicine
Oncology
Medicine
treatment response
Breast cancer

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations